| enzyme | | neonate | infant | child | adult | adult level | | | | | | | | | CYP1A1 | activity | ? | ? | ? | - | ? | | mRNA | ? | ? | ? | + | | | protein | + | ? | ? | ? | | | CYP1A2 | activity | +/- | + | +++ | +++ | at 5-6 month | | mRNA | - | + | +++ | +++ | | | protein | - | + | +++ | +++ | | | CYP2A6 | activity | ? | + | ++ | ++ | 6-13 years | | mRNA | ? | + | ++ | ++ | | | protein | ? | + | ++ | ++ | | | CYP2A7 | activity | ? | ? | ? | ? | ? | | mRNA | ? | ? | ? | + | | | protein | ? | ? | ? | ? | | | CYP2B(2B6,2B7) | activity | ? | ++ | ? | + | higher levels found in infant than adult | | mRNA | ? | ++ | ? | + | | | protein | ? | ++ | ? | + | | | CYP2C | mRNA | ++ | ++ | +++ | +++ | 30% of adult level from 1st week until 1 year | | protein | + | ++ | +++ | +++ | | | CYP2C8 | activity | ? | ? | ? | ? | ? | | CYP2C9 | activity | + | + | ++ | ++ | increasing in 1st week to 50% and adults level not before 1 year | | CYP2C18 | activity | ? | ? | ? | ? | ? | | CYP2C19 | activity | + | + | ++ | ++ | 9 months | | CYP2D6 | activity | +/- | + | + | + | ? | | mRNA | ++ | + | + | + | | | protein | +/- | + | + | + | | | CYP2E1 | activity | + | + | ++ | ++ | protein level after 9 months | | mRNA | +/- | + | ++ | ++ | | | protein | + | + | ++ | ++ | | | CYP3A4 | activity | +/- | ++ | +++ | +++ | in the first year replacing CYP3A7 | | mRNA | ? | ++ | +++ | +++ | | | protein | ? | ++ | +++ | +++ | | | CYP3A5 | activity | ? | ? | ? | ? | ? | | mRNA | + | + | ++ | ++ | | | protein | + | + | ++ | ++ | | | CYP3A7 | activity | ++ | + | - | - | activity is high in foetus, with a peak in the first week after birth and decrease in first year. | | mRNA | ? | ? | ? | ? | | | protein | ? | ? | ? | ? | | | UGT1A1 | activity | +/- | + | + | + | 3-6 months | | mRNA | ? | ? | ? | ? | | | protein | +/- | + | + | ? | | | UGT1A3 | activity | ? | ? | ? | - | ? | | mRNA | ? | ? | ? | + | | | protein | + | ? | ? | ? | | | NAT2 | activity | +/- | +/- | + | + | 10-12 months | | mRNA | ? | ? | ? | ? | | | protein | ? | ? | ? | ? | | | SULT | activity | + | + | + | + | from birth | | mRNA | ? | ? | ? | ? | | | protein | ? | ? | ? | ? | |
The development of CYP isozymes can be described with three major groups: · a foetal group that includes CYP3A7 and CYP4A1, mostly active on endogenous molecules, but also on some exogenous chemicals · an early neonatal group, which includes CYP2D6 and CYP2E1, that develop quickly during the hours or days after birth · the late neonatal CYPs, which develop later. CYP3A4 and CYP2C rise during the first weeks after birth and CYP1A2 being the last isoform to be expressed in the human liver. |